Precise Biometrics (PREC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Net sales for Q1 2026 were SEK 17.1 million, down 14.5% year-over-year, reflecting continued market uncertainty and lower production volumes, especially in the mobile segment.
Adjusted EBITDA turned positive at SEK 0.6 million, compared to SEK -1.7 million in Q1 2025, indicating improved cost control.
A strategic merger with Fingerprint Cards AB was announced and approved, expected to create significant synergies and strengthen market position.
Operating cash flow was positive at SEK 3.9 million, up from SEK 2.1 million in the prior year.
Annual Recurring Revenue (ARR) reached SEK 18.7 million, with cloud-based ARR surpassing on-premise for the first time.
Financial highlights
Net sales: SEK 17.1 million (Q1 2025: SEK 20.0 million), a 14.5% decrease year-over-year.
Gross margin: 71.8% (Q1 2025: 71.9%).
EBITDA: SEK -1.4 million (Q1 2025: SEK -1.7 million); Adjusted EBITDA: SEK 0.6 million (Q1 2025: SEK -1.7 million).
Operating profit (EBIT): SEK -5.8 million (Q1 2025: SEK -7.1 million); Adjusted EBIT: SEK -3.8 million (Q1 2025: SEK -7.1 million).
Earnings per share: SEK -0.07 (Q1 2025: SEK -0.09).
Cash and cash equivalents: SEK 18.9 million at period end (Q1 2025: SEK 36.0 million).
Outlook and guidance
Market remains challenging in the short term due to global uncertainty, especially in mobile and automotive sectors.
Long-term demand for biometric solutions is expected to grow, driven by security needs, regulatory requirements, and AI development.
The merger with Fingerprint Cards AB is expected to deliver at least SEK 45 million in annual cost synergies and support double-digit EBITDA margins.
Integration phase for the merger will be intensive, with completion targeted for early Q3 and a new share issue planned.
Latest events from Precise Biometrics
- Merger forms a global biometrics leader, targeting SEK 45 million in annual synergies by 2027.PREC
M&A announcement23 Mar 2026 - Positive EBITDA and cash flow achieved despite revenue decline and postponed customer volumes.PREC
Q4 202512 Feb 2026 - Positive EBITDA and stable ARR amid lower sales, with strong demand for biometric solutions.PREC
Q3 202514 Nov 2025 - Q2 saw stable sales and new biometric projects, but profitability was pressured by currency and customer shifts.PREC
Q2 202515 Aug 2025 - Q3 delivered strong growth, positive EBIT, and record margins, with robust outlook ahead.PREC
Q3 202413 Jun 2025 - Net sales and EBITDA rose, with ARR and new projects supporting growth outlook.PREC
Q2 202413 Jun 2025 - Fifth straight quarter of growth and positive EBITDA, with strong outlook for 2025.PREC
Q4 20245 Jun 2025 - Net sales fell 7.7% in Q1 2025, but growth prospects remain strong for the year.PREC
Q1 20255 Jun 2025